Drug pricing reform will threaten pharmaceutical industry

Published: 2011-06-29 06:59:00

Updated: 2011-06-29 06:59:00

The Korea Pharmaceutical Manufacturers Association (KPMA) said Monday that the country’s pharmaceutical sector could lose up to 1.5 trillion won until 2012 if the government is to implement reform on the pricing of drugs with potential price slashes both innovative and generic drugs.

In a rece...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK